New policy targets them, MECCs charge

Share this article:
With a two-year countdown ticking until a new med-ed policy takes effect, for-profit providers were taking stock of how they can comply. While clarity has been forthcoming, some in the med-ed community say another sought-after goal eludes them: parity.

In that regard, the situation hasn't changed much since April, when groups including the Coalition for Healthcare Communication lobbied the Accreditation Council for CME (ACCME) to apply its expanded definition of a “commercial interest” more evenly.

In a response notable for its forcefulness, Marty Cearnal, co-chair of the coalition's CME committee, charged that the policy creates “two classes of CME providers,” those for whom conflict of interest rules require action and those for whom they do not.

Murray Kopelow, MD, ACCME executive director, disagreed, saying the policy can include, “but is not limited to,” for-profit CME providers owned by or having a “business unit that does promotional work for commercial interests.”

Read: advertising agencies could have to create new holding companies to own their accredited provider (MM&M October 2007).

Most vexing to medical education and communication companies (MECCs), the executive director maintained that such requirements were relevant to all accredited providers “if the new definition of ‘commercial interest' applies to them.” Publishing companies, too, (but not journals like NEJM or JAMA) may need to restructure if their parent or sister company is engaged in an agency relationship. ACCME already groups MECCs with publishers in a single category, “Publishing/Education Company,” though.

The semantic brouhaha over the policy, part of a set of updates adopted in August, is not trivial; commercial interests may not be accredited.

Kopelow's talk at last month's AMA National Task Force meeting (scheduled to occur after press time), as well as the ACCME board's gathering this month, could offer further clarification.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.